BALDERTON SURGERY — All Prescriptions & Medications — Page 7

Practice Code: Y05369 | NEWARK, NG24 3HJ

Showing results 301-350 of 507

MedicationItems (12m) ↓QuantityCostvs National
371,260£165+37.7% ▲
378,170£335-63.6% ▼
Olmesartan medoxomil361,120£62-47.7% ▼
Neomycin sulfate36570£72-39.3% ▼
36380£1.2K+17.2% ▲
Alverine citrate35798£58-15.4% ▼
Tadalafil35180£39-79.4% ▼
35441£290-11.2% ▼
3537£177-14.0% ▼
Pancreatin347,292£1.7K-69.4% ▼
Glucose343,055£277-34.6% ▼
Brinzolamide/brimonidine34280£491-0.9% vs avg
Dorzolamide34340£226-59.1% ▼
34580£997-8.4% ▼
33199£259+0.6% vs avg
3346£7.2K-7.6% ▼
Combined ethinylestradiol 20mcg321,386£549-38.7% ▼
Carmellose sodium322,306£313-50.6% ▼
Emollient bath and shower preparations3215.0K£204-49.1% ▼
Coal tar3214.7K£305-56.0% ▼
3275£497-10.5% ▼
32350£85+147.8% ▲
Propantheline bromide312,548£2.1K+138.8% ▲
Hydrocortisone31741£198-59.2% ▼
Tibolone31896£80+1.3% vs avg
Colchicine31952£20-60.3% ▼
Benzydamine hydrochloride3110.7K£185-59.9% ▼
Sennosides307,200£136-2.9% ▼
Lacidipine301,232£105-74.9% ▼
Lithium carbonate301,467£204-76.4% ▼
Rotigotine30803£3.2K+11.2% ▲
Ferric maltol301,680£1.4K+130.6% ▲
30392£476-56.2% ▼
Levodopa/carbidopa/entacapone291,932£638+3.7% ▲
Dulaglutide29116£2.1K-74.7% ▼
Triptorelin2929£6.0K+37.5% ▲
29165£483+20.0% ▲
Cinnarizine283,192£144-40.2% ▼
Metoclopramide hydrochloride281,041£32-66.2% ▼
Co-trimoxazole(Trimethoprim/sulfamethoxazole)28832£50-30.3% ▼
Testosterone281,556£1.1K-63.3% ▼
Benzoyl peroxide28960£167+98.7% ▲
287,530£374-26.6% ▼
28393£186-16.1% ▼
Phosphates (Rectal)27356£21.9K+120.9% ▲
Co-amilofruse (Amiloride hydrochloride/frusemide)27924£141-22.4% ▼
Moxonidine271,022£144-51.5% ▼
Levomepromazine hydrochloride27209£401+17.3% ▲
Amantadine hydrochloride271,540£402-3.1% ▼
Metronidazole27400£22-58.9% ▼
← Back to BALDERTON SURGERY
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.